Abbott Cancer Diagnostics Reports Unspecified Data Breach in Illinois

Abbott Cancer Diagnostics, formerly known as Exact Sciences, submitted a data breach notification to the Illinois Attorney General's office on July 8, 2026. The incident, for which details are still being investigated, involved the exposure of personal information. The breach type and the precise date of compromise remain unknown at this time.

As a company focused on advanced molecular diagnostics and cancer screening, Abbott Cancer Diagnostics handles significant volumes of sensitive health-related data. While the specific categories of information exposed in this particular incident are not detailed in the public filing, such organizations typically manage comprehensive patient records.

The filing indicates that personal information was involved in the breach. However, the official report does not specify which particular types of data were affected. When personal information is compromised, individuals face potential risks that can include various forms of identity-related fraud or unwanted communications.

Individuals who receive a direct notification letter from Abbott Cancer Diagnostics should carefully review its contents for any guidance provided. It is generally advisable to monitor financial accounts and credit reports for any suspicious activity. Remaining cautious about unexpected communications, such as emails or phone calls asking for personal details, is also a recommended precaution.

This filing serves as a public record of the incident, originating from Abbott Cancer Diagnostics to the appropriate regulatory body in Illinois. The investigation into the scope and nature of the breach is ongoing, and further details may emerge as the process continues.